Home/Filings/4/0001140361-17-038920
4//SEC Filing

Simon Nicholas 4

Accession 0001140361-17-038920

CIK 0001409269other

Filed

Oct 16, 8:00 PM ET

Accepted

Oct 17, 6:43 PM ET

Size

22.5 KB

Accession

0001140361-17-038920

Insider Transaction Report

Form 4
Period: 2017-10-16
Transactions
  • Conversion

    Common Stock

    2017-10-16+3,389,1053,389,105 total
  • Conversion

    Series C Preferred Stock

    2017-10-163,389,1050 total
    Common Stock (3,389,105 underlying)
  • Conversion

    Convertible Promissory Note

    2017-10-160 total
    Exercise: $7.00Common Stock (180,881 underlying)
  • Conversion

    Common Stock

    2017-10-16$7.00/sh+180,881$1,266,1673,569,986 total
Transactions
  • Conversion

    Common Stock

    2017-10-16+3,389,1053,389,105 total
  • Conversion

    Common Stock

    2017-10-16$7.00/sh+180,881$1,266,1673,569,986 total
  • Conversion

    Series C Preferred Stock

    2017-10-163,389,1050 total
    Common Stock (3,389,105 underlying)
  • Conversion

    Convertible Promissory Note

    2017-10-160 total
    Exercise: $7.00Common Stock (180,881 underlying)
Transactions
  • Conversion

    Series C Preferred Stock

    2017-10-163,389,1050 total
    Common Stock (3,389,105 underlying)
  • Conversion

    Common Stock

    2017-10-16+3,389,1053,389,105 total
  • Conversion

    Common Stock

    2017-10-16$7.00/sh+180,881$1,266,1673,569,986 total
  • Conversion

    Convertible Promissory Note

    2017-10-160 total
    Exercise: $7.00Common Stock (180,881 underlying)
Transactions
  • Conversion

    Convertible Promissory Note

    2017-10-160 total
    Exercise: $7.00Common Stock (180,881 underlying)
  • Conversion

    Series C Preferred Stock

    2017-10-163,389,1050 total
    Common Stock (3,389,105 underlying)
  • Conversion

    Common Stock

    2017-10-16+3,389,1053,389,105 total
  • Conversion

    Common Stock

    2017-10-16$7.00/sh+180,881$1,266,1673,569,986 total
Transactions
  • Conversion

    Common Stock

    2017-10-16$7.00/sh+180,881$1,266,1673,569,986 total
  • Conversion

    Series C Preferred Stock

    2017-10-163,389,1050 total
    Common Stock (3,389,105 underlying)
  • Conversion

    Common Stock

    2017-10-16+3,389,1053,389,105 total
  • Conversion

    Convertible Promissory Note

    2017-10-160 total
    Exercise: $7.00Common Stock (180,881 underlying)
WHEELER KURT
10% Owner
Transactions
  • Conversion

    Series C Preferred Stock

    2017-10-163,389,1050 total
    Common Stock (3,389,105 underlying)
  • Conversion

    Common Stock

    2017-10-16+3,389,1053,389,105 total
  • Conversion

    Common Stock

    2017-10-16$7.00/sh+180,881$1,266,1673,569,986 total
  • Conversion

    Convertible Promissory Note

    2017-10-160 total
    Exercise: $7.00Common Stock (180,881 underlying)
HENNER DENNIS
10% Owner
Transactions
  • Conversion

    Common Stock

    2017-10-16+3,389,1053,389,105 total
  • Conversion

    Common Stock

    2017-10-16$7.00/sh+180,881$1,266,1673,569,986 total
  • Conversion

    Series C Preferred Stock

    2017-10-163,389,1050 total
    Common Stock (3,389,105 underlying)
  • Conversion

    Convertible Promissory Note

    2017-10-160 total
    Exercise: $7.00Common Stock (180,881 underlying)
LIPTAK ROBERT
10% Owner
Transactions
  • Conversion

    Series C Preferred Stock

    2017-10-163,389,1050 total
    Common Stock (3,389,105 underlying)
  • Conversion

    Convertible Promissory Note

    2017-10-160 total
    Exercise: $7.00Common Stock (180,881 underlying)
  • Conversion

    Common Stock

    2017-10-16+3,389,1053,389,105 total
  • Conversion

    Common Stock

    2017-10-16$7.00/sh+180,881$1,266,1673,569,986 total
Footnotes (4)
  • [F1]The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's Initial Public Offering (the "IPO").
  • [F2]The shares are directly held by Clarus Lifesciences II, L.P. ("Clarus"). Clarus Ventures II GP, L.P. (the "GPLP"), as the sole general partner of Clarus, may be deemed to beneficially own certain of the shares held by Clarus. Clarus Ventures II, LLC (the "GPLLC"), as the sole general partner of the GPLP, may be deemed to beneficially own certain of the shares held by Clarus. Each of he GPLP and the GPLLC disclaim beneficial ownership of all shares held by Clarus in which it does not have an actual pecuniary interest.
  • [F3]The expiration date is not relevant to the conversion of these securities.
  • [F4]The amount reported in column 5 is the principal amount of Reporting Person's Convertible Promissory Note (the "Note"). The outstanding principal and accrued interest of the Note automatically converted into shares of the Issuer's Common Stock at the price per share available to the public as set forth in the final prospectus related to the Issuer's IPO upon the closing of the IPO.

Documents

1 file

Issuer

Restoration Robotics Inc

CIK 0001409269

Entity typeother

Related Parties

1
  • filerCIK 0001431403

Filing Metadata

Form type
4
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 6:43 PM ET
Size
22.5 KB